Descriptive analysis of cochrane child-relevant systematic reviews: an update and comparison between 2009 and 2013

Katelynn Crick1,2, Denise Thomson3, Ricardo M Fernandes4,5

  • 1School of Public Health, University of Alberta, Edmonton, Canada. kccrick@ualberta.ca.

BMC Pediatrics
|July 12, 2017
PubMed

Insights

Child health systematic reviews increased 24% by 2013, with modest methodological advances. Evidence distribution across review groups shows discrepancies with global child mortality burdens, particularly for developing nations.

Area of Science:

  • Child Health Research
  • Systematic Reviews
  • Evidence Synthesis

Background:

  • Systematic reviews are crucial for health systems and clinical decision-making.
  • A 2009 description of child-relevant Cochrane systematic reviews exists.
  • This study updates and describes these reviews' content and methods.

Purpose of the Study:

  • To provide an updated description of child-relevant systematic reviews in the Cochrane Database of Systematic Reviews (CDSR).
  • To analyze the content and methodological approaches of these reviews.
  • To compare evidence distribution with global child disease burden.

Main Methods:

  • Identified child-relevant systematic reviews in CDSR as of March 2013.
  • Updated the Child Health Field Review Register (CHFRR).
  • Compared content and methods to 2009 data; mapped evidence to disease burden data.

Main Results:

  • 1,293 (23.4%) reviews were child-relevant, a 24% increase since 2009.
  • Airways, Cystic Fibrosis, and Infectious Diseases were common review groups.
  • Discrepancies noted between disease burden and evidence distribution, with underrepresentation from developing countries.

Conclusions:

  • Child-relevant systematic reviews in CDSR are a vital resource.
  • Modest methodological advancements were observed between 2009 and 2013.
  • Further analysis can identify priority areas for future child health systematic reviews.
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
503
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.2K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.4K
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
268
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
661
Chi-square Analysis02:46

Chi-square Analysis

The chi-square test is a statistical hypothesis test. It is used to check whether there is a significant difference between an expected value and an observed value. In the context of genetics, it enables us to either accept or reject a hypothesis, based on how much the observed values deviate from the expected values.
The chi-square test was developed by Pearson in 1990.
The first step of performing a Chi-square analysis is to establish a null hypothesis, which assumes that there is no real...
44.4K